Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by CASI Pharmaceuticals Holdings, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-23-126380 (34 Act) Size: 15 KB |
Dec-15-2023 | 231490197 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-23-124683 (34 Act) Size: 13 KB |
Dec-08-2023 | 231475429 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-23-118068 (34 Act) Size: 124 KB |
Nov-14-2023 | 231405849 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001193125-23-274511 (34 Act) Size: 85 KB |
Nov-09-2023 | 231392567 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-23-115498 (34 Act) Size: 30 KB |
Nov-08-2023 | 231385945 |
UPLOAD | Document | Acc-no: 0000000000-23-010316 ( Act) Size: 39 KB | Sep-19-2023 | |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001104659-23-095323 ( Act) Size: 29 KB |
Aug-25-2023 | |
UPLOAD | Document | Acc-no: 0000000000-23-008818 ( Act) Size: 44 KB | Aug-14-2023 | |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-23-090454 (34 Act) Size: 105 KB |
Aug-11-2023 | 231163877 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-23-086362 (34 Act) Size: 38 KB |
Aug-01-2023 | 231131739 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-23-082715 (34 Act) Size: 33 KB |
Jul-20-2023 | 231099818 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001193125-23-172891 (34 Act) Size: 85 KB |
Jun-23-2023 | 231034750 |
S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-23-063307 (33 Act) Size: 156 KB |
May-23-2023 | 23946334 |
S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-23-063304 (33 Act) Size: 156 KB |
May-23-2023 | 23946332 |
S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-23-063298 (33 Act) Size: 156 KB |
May-23-2023 | 23946328 |
S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-23-063297 (33 Act) Size: 156 KB |
May-23-2023 | 23946324 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-23-061641 (34 Act) Size: 13 KB |
May-17-2023 | 23929762 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-23-061616 (34 Act) Size: 100 KB |
May-17-2023 | 23929668 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-23-050327 (34 Act) Size: 26 KB |
Apr-26-2023 | 23849620 |
20-F | Document | Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Acc-no: 0001558370-23-006757 (34 Act) Size: 16551 KB |
Apr-26-2023 | 23847085 |
Recent 20 filings. View all CASI Pharmaceuticals Holdings, Inc. filings
Huge help thank you for your help .. y'all make it so much easier
Very good communication and delivery made within the timeframe I was advised of
It's being easier working on the website. And I recommend, it's a great website
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by